New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
05:44 EDTBIIBBiogen upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Biogen to Overweight citing upside potential from the company's multiple sclerosis franchise as well as its mid-stage pipeline opportunities. The firm raised its price target for shares to $375 from $300.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
11:23 EDTBIIBBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 7, 2014
07:24 EDTBIIBAlliance for Regenerative Medicine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use